Recognized as biomarkers for many types of malignant tumors, the CEA family were verified to be involved with tumorigenesis, cell adhesion, tumor angiogenesis, molecular signal transduction and tumor immunity. This evidence concerns the gene CEACAM5 and neoplasm.